Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Organon
Special Reports
The top 10 drugs losing US exclusivity in 2024
The unrelenting churning of time means many things to many people. For pharma execs, it’s a constant reminder of the need for new launches to supplant old meds.
Eric Sagonowsky
,
Fraiser Kansteiner
,
Zoey Becker
,
Angus Liu
,
Kevin Dunleavy
Mar 11, 2024 3:00am
NY attorney general wants FDA to tweak Singulair's safety label
Feb 27, 2024 9:25am
After Lilly accord, Organon's CEO is hungry to ink more deals
Feb 16, 2024 8:50am
Organon is taking over marketing of two Lilly meds in Europe
Dec 18, 2023 10:15am
Organon allies with Latin American bank to boost women's health
Jun 14, 2023 8:10am
Organon pledges $30M to improve contraceptive info
Mar 9, 2023 9:55am